Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

P6617

Sigma-Aldrich

Pristanic acid

≥97% (GC), ethanol solution

Sinónimos:

2,6,10,14-Tetramethylpentadecanoic acid

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C19H38O2
Número de CAS:
1189-37-3
Peso molecular:
298.50
EC Number:
200-578-6
MDL number:
MFCD05664739
UNSPSC Code:
12352106
PubChem Substance ID:
329820250
NACRES:
NA.77

Nombre del producto

Pristanic acid solution, mixture of isomers, ethanol solution, ≥97% (GC)

Quality Level

200

assay

≥97% (GC)

form

ethanol solution

storage temp.

−20°C

SMILES string

CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O

InChI

1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21)

InChI key

PAHGJZDQXIOYTH-UHFFFAOYSA-N

Biochem/physiol Actions

Oxidation product of fatty acids in the diet, particularly phytanic acid. Phytanic acid is oxidized by alpha oxidation yielding pristanic acid, which is subsequently degraded by peroxisomal beta oxidation. Several inborn errors of metabolism with one or more deficiencies in the phytanic acid and pristanic acid breakdown have been described.

pictograms

FlameExclamation mark
GHS02,GHS07

signalword

Danger

hcodes

H225,H319

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

Storage Class

3 - Flammable liquids

wgk_germany

WGK 2

flash_point_f

55.4 °F

flash_point_c

13 °C

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
0000343311
0000335727
SLCQ5703
SLCN4022
SLCM1895

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 7

1 of 7

Elaidic acid ≥99.0% (GC)

Sigma-Aldrich

E4637

Elaidic acid

Erucic acid ≥99% (capillary GC)

Sigma-Aldrich

E3385

Erucic acid

Behenic acid analytical standard

Supelco

11909

Behenic acid

Erucic acid analytical standard

Supelco

45629

Erucic acid

Palmitoleic acid ≥98.5% (GC), liquid

Sigma-Aldrich

P9417

Palmitoleic acid

Paraffin oil puriss., meets analytical specification of Ph. Eur., BP, viscous liquid

Sigma-Aldrich

18512

Paraffin oil

Ácido oleico ≥99% (GC)

Sigma-Aldrich

O1008

Ácido oleico

Phytanic and pristanic acid are naturally occuring ligands.
Anna W M Zomer et al.
Advances in experimental medicine and biology, 544, 247-254 (2004-01-10)
D S Roe et al.
Molecular genetics and metabolism, 87(1), 40-47 (2005-11-22)
The differentiation of carnitine-acylcarnitine translocase deficiency (CACT) from carnitine palmitoyltransferase type II deficiency (CPT-II) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency from mitochondrial trifunctional protein deficiency (MTP) continues to be ambiguous using current acylcarnitine profiling techniques either from plasma or blood
James A Mobley et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 12(8), 775-783 (2003-08-15)
An enzyme previously identified as alpha-methylacyl-CoA racemase (AMACR) is overexpressed in high-grade prostatic intraepithelial neoplasia and in a majority (60-100%) of prostate cancers (CaPs) as compared with normal and benign hyperplastic lesions of the prostate, where it is minimally expressed.
R J Wanders et al.
European journal of pediatrics, 153(7 Suppl 1), S44-S48 (1994-01-01)
Peroxisomal disorders represent a recently recognized group of inherited diseases in man, now comprising 14 different disorders. If discussion is restricted to those peroxisomal disorders in which there is neurological involvement (thereby excluding hyperoxaluria and acatalasaemia), results over the least
Antonella Peduto et al.
Molecular genetics and metabolism, 82(3), 224-230 (2004-07-06)
Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these, pipecolic acid evaluation is considered
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico